1 Study Coverage
    1.1 Generic Sterile Injectable Product Introduction
    1.2 Market by Type
        1.2.1 Global Generic Sterile Injectable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Monoclonal Antibodies
        1.2.3 Cytokines
        1.2.4 Insulin
        1.2.5 Peptide Hormones
        1.2.6 Vaccines
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Generic Sterile Injectable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Generic Sterile Injectable Sales Estimates and Forecasts 2017-2028
    2.2 Global Generic Sterile Injectable Revenue Estimates and Forecasts 2017-2028
    2.3 Global Generic Sterile Injectable Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Generic Sterile Injectable Sales by Region
        2.4.1 Global Generic Sterile Injectable Sales by Region (2017-2022)
        2.4.2 Global Sales Generic Sterile Injectable by Region (2023-2028)
    2.5 Global Generic Sterile Injectable Revenue by Region
        2.5.1 Global Generic Sterile Injectable Revenue by Region (2017-2022)
        2.5.2 Global Generic Sterile Injectable Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Generic Sterile Injectable Sales by Manufacturers
        3.1.1 Global Top Generic Sterile Injectable Manufacturers by Sales (2017-2022)
        3.1.2 Global Generic Sterile Injectable Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Generic Sterile Injectable in 2021
    3.2 Global Generic Sterile Injectable Revenue by Manufacturers
        3.2.1 Global Generic Sterile Injectable Revenue by Manufacturers (2017-2022)
        3.2.2 Global Generic Sterile Injectable Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Generic Sterile Injectable Revenue in 2021
    3.3 Global Generic Sterile Injectable Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Generic Sterile Injectable Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Generic Sterile Injectable Sales by Type
        4.1.1 Global Generic Sterile Injectable Historical Sales by Type (2017-2022)
        4.1.2 Global Generic Sterile Injectable Forecasted Sales by Type (2023-2028)
        4.1.3 Global Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    4.2 Global Generic Sterile Injectable Revenue by Type
        4.2.1 Global Generic Sterile Injectable Historical Revenue by Type (2017-2022)
        4.2.2 Global Generic Sterile Injectable Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    4.3 Global Generic Sterile Injectable Price by Type
        4.3.1 Global Generic Sterile Injectable Price by Type (2017-2022)
        4.3.2 Global Generic Sterile Injectable Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Generic Sterile Injectable Sales by Application
        5.1.1 Global Generic Sterile Injectable Historical Sales by Application (2017-2022)
        5.1.2 Global Generic Sterile Injectable Forecasted Sales by Application (2023-2028)
        5.1.3 Global Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    5.2 Global Generic Sterile Injectable Revenue by Application
        5.2.1 Global Generic Sterile Injectable Historical Revenue by Application (2017-2022)
        5.2.2 Global Generic Sterile Injectable Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    5.3 Global Generic Sterile Injectable Price by Application
        5.3.1 Global Generic Sterile Injectable Price by Application (2017-2022)
        5.3.2 Global Generic Sterile Injectable Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Generic Sterile Injectable Market Size by Type
        6.1.1 North America Generic Sterile Injectable Sales by Type (2017-2028)
        6.1.2 North America Generic Sterile Injectable Revenue by Type (2017-2028)
    6.2 North America Generic Sterile Injectable Market Size by Application
        6.2.1 North America Generic Sterile Injectable Sales by Application (2017-2028)
        6.2.2 North America Generic Sterile Injectable Revenue by Application (2017-2028)
    6.3 North America Generic Sterile Injectable Market Size by Country
        6.3.1 North America Generic Sterile Injectable Sales by Country (2017-2028)
        6.3.2 North America Generic Sterile Injectable Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Generic Sterile Injectable Market Size by Type
        7.1.1 Europe Generic Sterile Injectable Sales by Type (2017-2028)
        7.1.2 Europe Generic Sterile Injectable Revenue by Type (2017-2028)
    7.2 Europe Generic Sterile Injectable Market Size by Application
        7.2.1 Europe Generic Sterile Injectable Sales by Application (2017-2028)
        7.2.2 Europe Generic Sterile Injectable Revenue by Application (2017-2028)
    7.3 Europe Generic Sterile Injectable Market Size by Country
        7.3.1 Europe Generic Sterile Injectable Sales by Country (2017-2028)
        7.3.2 Europe Generic Sterile Injectable Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Generic Sterile Injectable Market Size by Type
        8.1.1 Asia Pacific Generic Sterile Injectable Sales by Type (2017-2028)
        8.1.2 Asia Pacific Generic Sterile Injectable Revenue by Type (2017-2028)
    8.2 Asia Pacific Generic Sterile Injectable Market Size by Application
        8.2.1 Asia Pacific Generic Sterile Injectable Sales by Application (2017-2028)
        8.2.2 Asia Pacific Generic Sterile Injectable Revenue by Application (2017-2028)
    8.3 Asia Pacific Generic Sterile Injectable Market Size by Region
        8.3.1 Asia Pacific Generic Sterile Injectable Sales by Region (2017-2028)
        8.3.2 Asia Pacific Generic Sterile Injectable Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Generic Sterile Injectable Market Size by Type
        9.1.1 Latin America Generic Sterile Injectable Sales by Type (2017-2028)
        9.1.2 Latin America Generic Sterile Injectable Revenue by Type (2017-2028)
    9.2 Latin America Generic Sterile Injectable Market Size by Application
        9.2.1 Latin America Generic Sterile Injectable Sales by Application (2017-2028)
        9.2.2 Latin America Generic Sterile Injectable Revenue by Application (2017-2028)
    9.3 Latin America Generic Sterile Injectable Market Size by Country
        9.3.1 Latin America Generic Sterile Injectable Sales by Country (2017-2028)
        9.3.2 Latin America Generic Sterile Injectable Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Generic Sterile Injectable Market Size by Type
        10.1.1 Middle East and Africa Generic Sterile Injectable Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Generic Sterile Injectable Revenue by Type (2017-2028)
    10.2 Middle East and Africa Generic Sterile Injectable Market Size by Application
        10.2.1 Middle East and Africa Generic Sterile Injectable Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Generic Sterile Injectable Revenue by Application (2017-2028)
    10.3 Middle East and Africa Generic Sterile Injectable Market Size by Country
        10.3.1 Middle East and Africa Generic Sterile Injectable Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Generic Sterile Injectable Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 3M
        11.1.1 3M Corporation Information
        11.1.2 3M Overview
        11.1.3 3M Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 3M Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 3M Recent Developments
    11.2 Baxter Inc
        11.2.1 Baxter Inc Corporation Information
        11.2.2 Baxter Inc Overview
        11.2.3 Baxter Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Baxter Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Baxter Inc Recent Developments
    11.3 Fresenius Kabi
        11.3.1 Fresenius Kabi Corporation Information
        11.3.2 Fresenius Kabi Overview
        11.3.3 Fresenius Kabi Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Fresenius Kabi Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Fresenius Kabi Recent Developments
    11.4 Pfizer/Hospira
        11.4.1 Pfizer/Hospira Corporation Information
        11.4.2 Pfizer/Hospira Overview
        11.4.3 Pfizer/Hospira Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Pfizer/Hospira Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Pfizer/Hospira Recent Developments
    11.5 Novartis/Sandoz
        11.5.1 Novartis/Sandoz Corporation Information
        11.5.2 Novartis/Sandoz Overview
        11.5.3 Novartis/Sandoz Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Novartis/Sandoz Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Novartis/Sandoz Recent Developments
    11.6 Teva
        11.6.1 Teva Corporation Information
        11.6.2 Teva Overview
        11.6.3 Teva Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Teva Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Teva Recent Developments
    11.7 Hikma
        11.7.1 Hikma Corporation Information
        11.7.2 Hikma Overview
        11.7.3 Hikma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Hikma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Hikma Recent Developments
    11.8 Sun Pharma
        11.8.1 Sun Pharma Corporation Information
        11.8.2 Sun Pharma Overview
        11.8.3 Sun Pharma Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sun Pharma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sun Pharma Recent Developments
    11.9 Dr. Reddy’s
        11.9.1 Dr. Reddy’s Corporation Information
        11.9.2 Dr. Reddy’s Overview
        11.9.3 Dr. Reddy’s Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Dr. Reddy’s Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Dr. Reddy’s Recent Developments
    11.10 Mylan
        11.10.1 Mylan Corporation Information
        11.10.2 Mylan Overview
        11.10.3 Mylan Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Mylan Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Mylan Recent Developments
    11.11 AstraZeneca Plc
        11.11.1 AstraZeneca Plc Corporation Information
        11.11.2 AstraZeneca Plc Overview
        11.11.3 AstraZeneca Plc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 AstraZeneca Plc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 AstraZeneca Plc Recent Developments
    11.12 Merck & Co., Inc
        11.12.1 Merck & Co., Inc Corporation Information
        11.12.2 Merck & Co., Inc Overview
        11.12.3 Merck & Co., Inc Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Merck & Co., Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Merck & Co., Inc Recent Developments
    11.13 Hellberg Safety Ab
        11.13.1 Hellberg Safety Ab Corporation Information
        11.13.2 Hellberg Safety Ab Overview
        11.13.3 Hellberg Safety Ab Generic Sterile Injectable Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Hellberg Safety Ab Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Hellberg Safety Ab Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Generic Sterile Injectable Industry Chain Analysis
    12.2 Generic Sterile Injectable Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Generic Sterile Injectable Production Mode & Process
    12.4 Generic Sterile Injectable Sales and Marketing
        12.4.1 Generic Sterile Injectable Sales Channels
        12.4.2 Generic Sterile Injectable Distributors
    12.5 Generic Sterile Injectable Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Generic Sterile Injectable Industry Trends
    13.2 Generic Sterile Injectable Market Drivers
    13.3 Generic Sterile Injectable Market Challenges
    13.4 Generic Sterile Injectable Market Restraints
14 Key Findings in The Global Generic Sterile Injectable Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Generic Sterile Injectable Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Monoclonal Antibodies
    Table 3. Major Manufacturers of Cytokines
    Table 4. Major Manufacturers of Insulin
    Table 5. Major Manufacturers of Peptide Hormones
    Table 6. Major Manufacturers of Vaccines
    Table 7. Major Manufacturers of Others
    Table 8. Global Generic Sterile Injectable Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Generic Sterile Injectable Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Generic Sterile Injectable Sales by Region (2017-2022) & (K Units)
    Table 11. Global Generic Sterile Injectable Sales Market Share by Region (2017-2022)
    Table 12. Global Generic Sterile Injectable Sales by Region (2023-2028) & (K Units)
    Table 13. Global Generic Sterile Injectable Sales Market Share by Region (2023-2028)
    Table 14. Global Generic Sterile Injectable Revenue by Region (2017-2022) & (US$ Million)
    Table 15. Global Generic Sterile Injectable Revenue Market Share by Region (2017-2022)
    Table 16. Global Generic Sterile Injectable Revenue by Region (2023-2028) & (US$ Million)
    Table 17. Global Generic Sterile Injectable Revenue Market Share by Region (2023-2028)
    Table 18. Global Generic Sterile Injectable Sales by Manufacturers (2017-2022) & (K Units)
    Table 19. Global Generic Sterile Injectable Sales Share by Manufacturers (2017-2022)
    Table 20. Global Generic Sterile Injectable Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 21. Global Generic Sterile Injectable Revenue Share by Manufacturers (2017-2022)
    Table 22. Generic Sterile Injectable Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 23. Global Generic Sterile Injectable Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Generic Sterile Injectable by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Sterile Injectable as of 2021)
    Table 25. Generic Sterile Injectable Manufacturing Base Distribution and Headquarters
    Table 26. Manufacturers Generic Sterile Injectable Product Offered
    Table 27. Date of Manufacturers Enter into Generic Sterile Injectable Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Generic Sterile Injectable Sales by Type (2017-2022) & (K Units)
    Table 30. Global Generic Sterile Injectable Sales by Type (2023-2028) & (K Units)
    Table 31. Global Generic Sterile Injectable Sales Share by Type (2017-2022)
    Table 32. Global Generic Sterile Injectable Sales Share by Type (2023-2028)
    Table 33. Global Generic Sterile Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 34. Global Generic Sterile Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 35. Global Generic Sterile Injectable Revenue Share by Type (2017-2022)
    Table 36. Global Generic Sterile Injectable Revenue Share by Type (2023-2028)
    Table 37. Generic Sterile Injectable Price by Type (2017-2022) & (USD/Unit)
    Table 38. Global Generic Sterile Injectable Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 39. Global Generic Sterile Injectable Sales by Application (2017-2022) & (K Units)
    Table 40. Global Generic Sterile Injectable Sales by Application (2023-2028) & (K Units)
    Table 41. Global Generic Sterile Injectable Sales Share by Application (2017-2022)
    Table 42. Global Generic Sterile Injectable Sales Share by Application (2023-2028)
    Table 43. Global Generic Sterile Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 44. Global Generic Sterile Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 45. Global Generic Sterile Injectable Revenue Share by Application (2017-2022)
    Table 46. Global Generic Sterile Injectable Revenue Share by Application (2023-2028)
    Table 47. Generic Sterile Injectable Price by Application (2017-2022) & (USD/Unit)
    Table 48. Global Generic Sterile Injectable Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 49. North America Generic Sterile Injectable Sales by Type (2017-2022) & (K Units)
    Table 50. North America Generic Sterile Injectable Sales by Type (2023-2028) & (K Units)
    Table 51. North America Generic Sterile Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 52. North America Generic Sterile Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 53. North America Generic Sterile Injectable Sales by Application (2017-2022) & (K Units)
    Table 54. North America Generic Sterile Injectable Sales by Application (2023-2028) & (K Units)
    Table 55. North America Generic Sterile Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 56. North America Generic Sterile Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 57. North America Generic Sterile Injectable Sales by Country (2017-2022) & (K Units)
    Table 58. North America Generic Sterile Injectable Sales by Country (2023-2028) & (K Units)
    Table 59. North America Generic Sterile Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 60. North America Generic Sterile Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 61. Europe Generic Sterile Injectable Sales by Type (2017-2022) & (K Units)
    Table 62. Europe Generic Sterile Injectable Sales by Type (2023-2028) & (K Units)
    Table 63. Europe Generic Sterile Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 64. Europe Generic Sterile Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 65. Europe Generic Sterile Injectable Sales by Application (2017-2022) & (K Units)
    Table 66. Europe Generic Sterile Injectable Sales by Application (2023-2028) & (K Units)
    Table 67. Europe Generic Sterile Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 68. Europe Generic Sterile Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 69. Europe Generic Sterile Injectable Sales by Country (2017-2022) & (K Units)
    Table 70. Europe Generic Sterile Injectable Sales by Country (2023-2028) & (K Units)
    Table 71. Europe Generic Sterile Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 72. Europe Generic Sterile Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Generic Sterile Injectable Sales by Type (2017-2022) & (K Units)
    Table 74. Asia Pacific Generic Sterile Injectable Sales by Type (2023-2028) & (K Units)
    Table 75. Asia Pacific Generic Sterile Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Generic Sterile Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Generic Sterile Injectable Sales by Application (2017-2022) & (K Units)
    Table 78. Asia Pacific Generic Sterile Injectable Sales by Application (2023-2028) & (K Units)
    Table 79. Asia Pacific Generic Sterile Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Generic Sterile Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 81. Asia Pacific Generic Sterile Injectable Sales by Region (2017-2022) & (K Units)
    Table 82. Asia Pacific Generic Sterile Injectable Sales by Region (2023-2028) & (K Units)
    Table 83. Asia Pacific Generic Sterile Injectable Revenue by Region (2017-2022) & (US$ Million)
    Table 84. Asia Pacific Generic Sterile Injectable Revenue by Region (2023-2028) & (US$ Million)
    Table 85. Latin America Generic Sterile Injectable Sales by Type (2017-2022) & (K Units)
    Table 86. Latin America Generic Sterile Injectable Sales by Type (2023-2028) & (K Units)
    Table 87. Latin America Generic Sterile Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 88. Latin America Generic Sterile Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 89. Latin America Generic Sterile Injectable Sales by Application (2017-2022) & (K Units)
    Table 90. Latin America Generic Sterile Injectable Sales by Application (2023-2028) & (K Units)
    Table 91. Latin America Generic Sterile Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 92. Latin America Generic Sterile Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 93. Latin America Generic Sterile Injectable Sales by Country (2017-2022) & (K Units)
    Table 94. Latin America Generic Sterile Injectable Sales by Country (2023-2028) & (K Units)
    Table 95. Latin America Generic Sterile Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 96. Latin America Generic Sterile Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Generic Sterile Injectable Sales by Type (2017-2022) & (K Units)
    Table 98. Middle East and Africa Generic Sterile Injectable Sales by Type (2023-2028) & (K Units)
    Table 99. Middle East and Africa Generic Sterile Injectable Revenue by Type (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Generic Sterile Injectable Revenue by Type (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Generic Sterile Injectable Sales by Application (2017-2022) & (K Units)
    Table 102. Middle East and Africa Generic Sterile Injectable Sales by Application (2023-2028) & (K Units)
    Table 103. Middle East and Africa Generic Sterile Injectable Revenue by Application (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Generic Sterile Injectable Revenue by Application (2023-2028) & (US$ Million)
    Table 105. Middle East and Africa Generic Sterile Injectable Sales by Country (2017-2022) & (K Units)
    Table 106. Middle East and Africa Generic Sterile Injectable Sales by Country (2023-2028) & (K Units)
    Table 107. Middle East and Africa Generic Sterile Injectable Revenue by Country (2017-2022) & (US$ Million)
    Table 108. Middle East and Africa Generic Sterile Injectable Revenue by Country (2023-2028) & (US$ Million)
    Table 109. 3M Corporation Information
    Table 110. 3M Description and Major Businesses
    Table 111. 3M Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. 3M Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. 3M Recent Developments
    Table 114. Baxter Inc Corporation Information
    Table 115. Baxter Inc Description and Major Businesses
    Table 116. Baxter Inc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Baxter Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Baxter Inc Recent Developments
    Table 119. Fresenius Kabi Corporation Information
    Table 120. Fresenius Kabi Description and Major Businesses
    Table 121. Fresenius Kabi Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Fresenius Kabi Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Fresenius Kabi Recent Developments
    Table 124. Pfizer/Hospira Corporation Information
    Table 125. Pfizer/Hospira Description and Major Businesses
    Table 126. Pfizer/Hospira Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Pfizer/Hospira Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Pfizer/Hospira Recent Developments
    Table 129. Novartis/Sandoz Corporation Information
    Table 130. Novartis/Sandoz Description and Major Businesses
    Table 131. Novartis/Sandoz Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Novartis/Sandoz Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Novartis/Sandoz Recent Developments
    Table 134. Teva Corporation Information
    Table 135. Teva Description and Major Businesses
    Table 136. Teva Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 137. Teva Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Teva Recent Developments
    Table 139. Hikma Corporation Information
    Table 140. Hikma Description and Major Businesses
    Table 141. Hikma Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 142. Hikma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Hikma Recent Developments
    Table 144. Sun Pharma Corporation Information
    Table 145. Sun Pharma Description and Major Businesses
    Table 146. Sun Pharma Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 147. Sun Pharma Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Sun Pharma Recent Developments
    Table 149. Dr. Reddy’s Corporation Information
    Table 150. Dr. Reddy’s Description and Major Businesses
    Table 151. Dr. Reddy’s Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 152. Dr. Reddy’s Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Dr. Reddy’s Recent Developments
    Table 154. Mylan Corporation Information
    Table 155. Mylan Description and Major Businesses
    Table 156. Mylan Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 157. Mylan Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Mylan Recent Developments
    Table 159. AstraZeneca Plc Corporation Information
    Table 160. AstraZeneca Plc Description and Major Businesses
    Table 161. AstraZeneca Plc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 162. AstraZeneca Plc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 163. AstraZeneca Plc Recent Developments
    Table 164. Merck & Co., Inc Corporation Information
    Table 165. Merck & Co., Inc Description and Major Businesses
    Table 166. Merck & Co., Inc Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 167. Merck & Co., Inc Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 168. Merck & Co., Inc Recent Developments
    Table 169. Hellberg Safety Ab Corporation Information
    Table 170. Hellberg Safety Ab Description and Major Businesses
    Table 171. Hellberg Safety Ab Generic Sterile Injectable Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 172. Hellberg Safety Ab Generic Sterile Injectable Product Model Numbers, Pictures, Descriptions and Specifications
    Table 173. Hellberg Safety Ab Recent Developments
    Table 174. Key Raw Materials Lists
    Table 175. Raw Materials Key Suppliers Lists
    Table 176. Generic Sterile Injectable Distributors List
    Table 177. Generic Sterile Injectable Customers List
    Table 178. Generic Sterile Injectable Market Trends
    Table 179. Generic Sterile Injectable Market Drivers
    Table 180. Generic Sterile Injectable Market Challenges
    Table 181. Generic Sterile Injectable Market Restraints
    Table 182. Research Programs/Design for This Report
    Table 183. Key Data Information from Secondary Sources
    Table 184. Key Data Information from Primary Sources
List of Figures
    Figure 1. Generic Sterile Injectable Product Picture
    Figure 3. Global Generic Sterile Injectable Market Share by Type in 2021 & 2028
    Figure 3. Monoclonal Antibodies Product Picture
    Figure 4. Cytokines Product Picture
    Figure 5. Insulin Product Picture
    Figure 6. Peptide Hormones Product Picture
    Figure 7. Vaccines Product Picture
    Figure 8. Others Product Picture
    Figure 9. Global Generic Sterile Injectable Market Share by Application in 2021 & 2028
    Figure 10. Hospitals
    Figure 11. Pharmacies
    Figure 12. Online Pharmacies
    Figure 13. Generic Sterile Injectable Report Years Considered
    Figure 14. Global Generic Sterile Injectable Sales 2017-2028 (K Units)
    Figure 15. Global Generic Sterile Injectable Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Generic Sterile Injectable Revenue 2017-2028 (US$ Million)
    Figure 17. Global Generic Sterile Injectable Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Generic Sterile Injectable Sales Market Share by Region (2017-2022)
    Figure 19. Global Generic Sterile Injectable Sales Market Share by Region (2023-2028)
    Figure 20. North America Generic Sterile Injectable Sales YoY (2017-2028) & (K Units)
    Figure 21. North America Generic Sterile Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Generic Sterile Injectable Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe Generic Sterile Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Generic Sterile Injectable Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific Generic Sterile Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Generic Sterile Injectable Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America Generic Sterile Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Generic Sterile Injectable Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa Generic Sterile Injectable Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Generic Sterile Injectable Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Generic Sterile Injectable in the World: Market Share by Generic Sterile Injectable Revenue in 2021
    Figure 32. Global Generic Sterile Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    Figure 34. Global Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    Figure 35. Global Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    Figure 36. Global Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    Figure 37. North America Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    Figure 38. North America Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    Figure 39. North America Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    Figure 40. North America Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    Figure 41. North America Generic Sterile Injectable Sales Share by Country (2017-2028)
    Figure 42. North America Generic Sterile Injectable Revenue Share by Country (2017-2028)
    Figure 43. U.S. Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    Figure 46. Europe Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    Figure 48. Europe Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Generic Sterile Injectable Sales Share by Country (2017-2028)
    Figure 50. Europe Generic Sterile Injectable Revenue Share by Country (2017-2028)
    Figure 51. Germany Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 52. France Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Generic Sterile Injectable Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Generic Sterile Injectable Revenue Share by Region (2017-2028)
    Figure 62. China Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 65. India Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Generic Sterile Injectable Sales Share by Country (2017-2028)
    Figure 77. Latin America Generic Sterile Injectable Revenue Share by Country (2017-2028)
    Figure 78. Mexico Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Generic Sterile Injectable Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Generic Sterile Injectable Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Generic Sterile Injectable Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Generic Sterile Injectable Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Generic Sterile Injectable Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Generic Sterile Injectable Revenue Share by Country (2017-2028)
    Figure 87. Turkey Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Generic Sterile Injectable Revenue (2017-2028) & (US$ Million)
    Figure 90. Generic Sterile Injectable Value Chain
    Figure 91. Generic Sterile Injectable Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed